A revolutionary new blood test is set to be rolled out in the UK's National Health Service (NHS) to help doctors assess women suspected of having womb cancer before undergoing invasive tests. The test, developed using artificial intelligence (AI), aims to identify subtle changes in the blood that may indicate an increased risk of the disease.
According to a recent article by The Guardian, around 90,000 postmenopausal women in England are referred to hospitals each year after experiencing heavy bleeding, which is often a symptom of womb cancer. However, these referrals can lead to unnecessary invasive tests and procedures for many patients, which can have serious health consequences.
The NHS AI blood test has the potential to significantly reduce the number of invasive checks required, potentially halving the number of women undergoing unnecessary tests. The test involves analyzing blood samples from patients who are referred for possible womb cancer, using machine learning algorithms to identify patterns and anomalies that may indicate an increased risk of the disease.